Share Name Share Symbol Market Type Share ISIN Share Description
Deltex Medical Group Plc LSE:DEMG London Ordinary Share GB0059337583 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 1.125 1.05 1.20 1.125 1.125 1.13 1,636 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 5.0 -1.3 -0.3 - 6

Deltex Medical Share Discussion Threads

Showing 20651 to 20675 of 20850 messages
Chat Pages: 834  833  832  831  830  829  828  827  826  825  824  823  Older
DateSubjectAuthorDiscuss
23/9/2019
09:39
>>Nobbygnome Not got anything >>DJ Trading Buyers are far more likely after the Cheetah deal, especially as DEMG has a fully approved direct competitor technology to Cheetah's on its platform already; one of the most likely buyers is being very nice to them indeed with a $0.25m payment in H2; your underlying cash burn number is wildly over done: looks like they are averaging £10,000 to £20,000 a month positive going into stronger second half with grants, $0.25m termination bonus as well as option exercise cash to come; the third party product will have been set up at a 40% margin for DEMG as distributor but this will have fallen to closer to 20% post Brexit referendum sterling devaluation - call it 30% or £120,000 gross margin a year and they are about to get compensated for nearly two years loss of margin while saving all the direct and indirect overhead; they are also getting grants towards new products and a new monitor will given them a whole new revenue stream as they haven't been selling the 20 year old model for some time now dyor
schloo
23/9/2019
08:49
Nobby - Yes they have done the right thing taking out costs - they had no choice! But annual Revenue has fallen to circa £4m and underlying cash burn is still nearly £0.5m/annum so they still have more to do. I can't see how they are going to increase Revenue having not managed to do it with a bloated sales force and lots of supporting evidence about the product. I hope they can turn things around but I just can't see how and if a buyer was interested I think they would have made a move before now imo
dj trading
23/9/2019
08:43
>>schloo Just sent you an email....
nobbygnome
23/9/2019
08:42
Increasing gross margins from 68% to 76% partly by increasing US prices is a positive.
janatha
23/9/2019
08:41
>> DJ You are talking semantics. Do you agree the business is now stable and has the chance to grow albeit slowly?
nobbygnome
23/9/2019
08:36
"Nobbygnome23 >> DJ Getting rid of non profitable turnover and freeing up reps to be more productive is a good thing IMHO. You comments are disingenuous..." The contract was profitable even with the "fully-loaded expenses associated with selling and supporting this equipment" they say "not significantly profitable" Re "Your comments are disingenuous" perhaps, but yours are incorrect "non profitable turnover"! So a small reduction in profit but a much larger loss of GM and those costs will either have to generate more Revenue or be taken out to maintain profitability/cash flow and not much sign of an imminent increase in revenue to replace the loss of this contract imo
dj trading
23/9/2019
08:36
DJ Trading You are forgetting that the reduction in debtors is mostly offset by a reduction in short term borrowings (an invoice discounting facility) of an average of £47k/month Key point is that DEMG does not need to raise more capital so price should correct. Note that Cheetah was still burning cash when bought at a value equivalent to at least 10 times current DEMG within the last fortnight
schloo
23/9/2019
08:27
"Nobbygnome23 Sep '19 - 09:06 - 10382 of 10385 Cash flow positive not profitable! Cash is the most important aspect as that means we won’t have further fund raisings. What we want is a stable organically growing (albeit slowly) business....and now have IMHO." Agree cash most important as I have been saying for years! But cash gen of £20k/month in 1H mainly attributable to other movements in working capital as I said in my table above "beneficial move of other working cap items - stock/debtors and creditors of £61k/month" so an adjusted monthly burn of around £40k/month dyor
dj trading
23/9/2019
08:27
DJ Trading, Nobbygnome Despite your different tones, I suspect you are both broadly right The $250,000 payment expected before year end seems like a very generous settlement designed to keep DEMG sweet. Any thoughts as to who is making this payment?
schloo
23/9/2019
08:25
>> DJ Getting rid of non profitable turnover and freeing up reps to be more productive is a good thing IMHO. You comments are disingenuous...
nobbygnome
23/9/2019
08:21
Are you seriously saying that a trade this morning for 0.0001% of the company and £81.11 means anything?DEMG is cash positive, profitable and worth at least two or three times its current valuation
mrc2u
23/9/2019
08:21
And I guess the real question is what is the company worth to a potential acquirer! It seems clear to me that the recent process of improving the balance sheet is all about looking to be bought. Yes it probably won’t happen in the short term but that is the inevitable outcome here at some point in the not too distant future IMHO.
nobbygnome
23/9/2019
08:19
From 1H report "Deltex Medical has, for a number of years, distributed into the UK market complementary products manufactured by third-party companies. One of these companies, which manufactures pulse oximetry equipment, was recently purchased by a competitor. Negotiations have recently concluded in respect of the termination of Deltex Medical's UK distribution contract relating to this equipment which is expected to give rise to, among other things, the payment to the Group of US$0.25 million before the year-end. In 2018, the revenues associated with this third-party equipment totalled £0.4 million; however, once an estimate of the 2018 fully-loaded expenses associated with selling and supporting this equipment are deducted from the 2018 gross margin generated by such sales, the product line was not significantly profitable" So they will have to further reduce "expenses associated with selling and supporting this equipment" sales staff? A one off cash payment of circa £0.2m in 2H but reduction of £0.4m revenue and associated GM for future years. As I said on the 27th Aug - Business sadly appears to be in terminal decline and will struggle against well funded and much larger competitors even if Deltex have the best product? imo imo dyor DJT
dj trading
23/9/2019
08:11
Net cash generated from operations of £0.3m is an excellent result and clearly shows the cash position improving. You would expect them to have increased stocks in first half because sales are always stronger in second half. You would expect them to reduce debtors in first half because they are collecting the cash from the stronger second half sales You are being unduly negative about profitability. Being EBITDA positive is a major milestone in itself, but you need to look also at the operating loss before exceptional line. H1 was £0.2m down £0.9m from £1.1m in 2018 which is a dramatic improvement. BUT second half last year was already profitable by £0.1m pre exceptionals so that is an operating loss of less than £0.1m over the last 12 months. At worst you can say this is now break-even and well on track to be profitable for the year and that is very good news especially when added to it being cash positive
schloo
23/9/2019
08:06
Why did somebody sell 1M shares then after close on friday ? 16:33:19 1.30 1.00m 1.30 1.35 16,000 shares bought first thing at 1.37 6,339 shares sold a minute later at 1.30 That is all , no buyers buying in IMO because turnover is dropping and even after nearly 50% of staff have been cut reducing overheads DEMG is still reporting a loss.
buywell3
23/9/2019
08:06
Cash flow positive not profitable! Cash is the most important aspect as that means we won’t have further fund raisings. What we want is a stable organically growing (albeit slowly) business....and now have IMHO.
nobbygnome
23/9/2019
07:54
Quiet here on results day! PBT -£307k as predicted "DJ Trading - 27 Aug 2019 - 23:01:58 - 10264 of 10381 I note several posters here saying DEMG now profitable But the TS says "positive adjusted EBITDA" that isn't profit in my book especially with significant interest, depreciation and amortisation charges (some of which is cash - ie interest and capitalised deve exp was £0.4m last full year) My guess PBT for 1H19 -£0.3m or worse"
dj trading
23/9/2019
07:51
Monthly cash burn (Movement in cash balance + financing) 2010 Rev £6.3m Burn £95k/month 2011 Rev £6.3m Burn £157k/month 2012 Rev £6.8m Burn £162k/month 2013 Rev £7.2m Burn £197k/month 2014 Rev £6.5m Burn £220k/month 2015 Rev £6.4m Burn £180k/month 2016 Rev £6.3m Burn £198k/month 2017 Rev £5.9m Burn £102k/month 2018 Rev £5.0m Burn £128k/month (1H18 Burn £158k/month 2H18 Burn 98k/month) 1H19 Rev £2.0m Gen. £20k/month* (*But note beneficial move of other working cap items - stock/debtors and creditors of £61k/month) dyor etc.
dj trading
23/9/2019
07:47
Cash generated from operations of 0.3m with more to come from grants, Edwards Lifesciences and option exercises in second halfPositive EBITDA of 0.2mBoth achieved in the first half with second half both always stronger and off to a good startAll sounds good and reconfirms that this business is cash positive, profitable and worth at least two or three times its current market cap
mrc2u
23/9/2019
07:13
Still loss making despite all the staff cuts as sales fall in key countries Sales of probes in the UK and the US have dropped by around 18% ( see the tables lower in the results) Only 19,000 pounds worth of monitor sales in both countries , which was probable one in the NHS , but that was 19,000 pounds more than nothing from monitor sales in 30/6/2018 results. Even worse in France where the ramp brigade was going ape when news of a deal was RNS's a couple of years ago Probe sales have dropped by close to 40% in France V 30/06/2018 Even worse NO monitors were sold at all in France dyor
buywell3
23/9/2019
06:29
The statement reads well enough on a first glance. Various encouraging aspects which certainly mean the fall from 1.6p achieved when the trading statement was released in July is unmerited. We have a cash flow positive business with various avenues of possible growth.
nobbygnome
23/9/2019
06:28
Interims look good0.3m of net cash generated from operations0.2m of cash to come from UK third party product supplier and 0.1m from R&D grants (plus option exercise cash)Gross profit protected by US price increasesVizient GPO deal looking very promisingTrading has started well in the second half and warm noises about growth
mrc2u
22/9/2019
20:08
janatha (10370) "900,000 shares bought 1.4p." Did all those shares club together to raise 1.4p? That would make about 0.000001555555 pence each.
arf dysg
22/9/2019
19:15
The late 1 million sell explains everything. Now we wait for the announcement tomorrow morning. If they state that the cash flow positivity is continuing and expected to for the rest of the second half then the price should react positively. Don’t forget the sales are always weighted to the second half so it would be surprising if they weren’t strongly cash flow positive for the full year!
nobbygnome
20/9/2019
15:50
The market cap here is less than the £10m.The thought that the MMs do anything other than let the algos do their thing is laughable.
qazwsxedc69
Chat Pages: 834  833  832  831  830  829  828  827  826  825  824  823  Older
Your Recent History
LSE
DEMG
Deltex Med..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191206 11:01:46